Wegovy has an FDA-approved indication to reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal heart attack, and nonfatal stroke, in adults with established cardiovascular disease and either obesity or overweight
Peptide therapy is not recommended for individuals who are: -Pregnant or breastfeeding -Diagnosed with active cancer or hormone-sensitive tumors or high risk -Undergoing immunosuppressive therapy (unless cleared by their specialist) -Experiencing uncontrolled endocrine disorders Always consult your provider and disclose your full medical history before starting any peptide protocol
Tsai AC, Romsos DR, Leveille GA
Lee et al., 2021)]
PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, providing access to GLP-1 therapy without the stimulant pathway risks
Mark Cuban (32:45): If the government decides, well, instead of Medicare Advantage the way it was, we know all the costs